Home/Rare Diseases/Phenylketonuria
Metabolic & Lysosomal

Phenylketonuria

Affects approximately
1 in 10,000 to 15,000 newborns in the U.S.

Also known as: PKU

Phenylketonuria

About Phenylketonuria

Phenylketonuria (PKU) is an inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which normally converts the amino acid phenylalanine into tyrosine. Without this enzyme, phenylalanine accumulates to toxic levels in the blood and cerebrospinal fluid, causing intellectual disability, behavioral problems, and neurological complications if left untreated. Fortunately, PKU is one of the first conditions routinely screened for in newborns across the U.S. and many other developed countries. When identified early and managed properly through a specialized low-phenylalanine diet, individuals with PKU can have normal intellectual development and a normal lifespan. However, maintaining the strict dietary requirements throughout childhood and often into adulthood is essential, as uncontrolled phenylalanine levels can develop at any age.

Common Symptoms

  • Light-colored skin and hair
  • Musty or mousy odor in sweat or urine
  • Intellectual disability if untreated
  • Behavioral problems or hyperactivity
  • Eczema or other skin conditions
  • Seizures in severe untreated cases

Who It Affects

Typically identified in newborns through screening; affects males and females equally. More common in individuals of Scandinavian, Celtic, and Eastern European descent.

Getting Involved in Clinical Trials

Clinical trials for PKU are exploring enzyme replacement therapies, gene therapies, and new drugs like pegvaliase (Palynziq) that can help reduce dietary restrictions. The National Institutes of Health and PKU patient registries maintain current trial information. The National Organization for Rare Disorders (NORD) and the PKU Foundation are excellent resources for finding trials and connecting with other families managing the condition. Your metabolic specialist can help determine trial eligibility and discuss whether participation might reduce the need for strict dietary management.

Trusted Sources

Active Clinical Trials for Phenylketonuria

Finding trials for Phenylketonuria...

Related Metabolic & Lysosomal Conditions

Metabolic & Lysosomal

Wilson Disease

Wilson disease is a rare inherited disorder where the body accumulates toxic levels of copper, primarily in the liver, b...

Metabolic & Lysosomal

Fabry Disease

Fabry disease is a rare inherited lysosomal storage disorder where a missing enzyme causes fatty substances called globo...

Metabolic & Lysosomal

Pompe Disease

Pompe disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme acid alpha-glucosidase, ...